Recent research at University of Kentucky, USA demonstrated the significant effect of CurQfen®, to reduce the aortic stiffness and brachial pulse pressure in young obese individuals by up-regulating the anti-inflammatory cytokines, when supplemented at just 500 mg/day.
The results of the double blinded randomized placebo-controlled study assume significance from the fact that aortic stiffness is directly linked to CV risks and CV mortality. Earlier human clinical trials also indicated the enhanced effect of CurQfen® in reducing the stress, anxiety and fatigue with a significant elevation in endogenous antioxidants such as glutathione. The remarkable ability of CurQfen® in reducing lipid peroxidation with detoxification potential also demonstrated the potential of CurQfen® to ameliorate cardiovascular risks. The uniqueness of CurQfen® lies in its ability to provide the bioactive free-form of curcuminoids to plasma and further into tissues, with improved blood-brain-barrier permeability. CurQfen® is setting up a new benchmark in bioavailability of curcumin, more than just the absorption of curcumin glucuronides to plasma!